Ads
related to: fda approved for postpartum depressionbabylist.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
The US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral ...
Zuranolone was approved by the US Food and Drug Administration (FDA) for the treatment of postpartum depression in August 2023. [6] [13] The FDA granted the application for zuranolone priority review and fast track designations. [6] Approval of Zurzuvae was granted to Sage Therapeutics, Inc. [6]
The approval of this new medication can help alleviate the stigma associated with postpartum depression, Hillary Ammon, a clinical psychologist at the Center for Anxiety & Women's Emotional ...
The first-ever pill for postpartum depression, zuranolone, was approved last year. ... The Food and Drug Administration approved the drug in August, but it took months for supply to become ...
Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple weeks, it can continue for months or even years. ... The FDA approved that drug ...
The companies had sought the FDA's approval for the drug, Zurzuvae, to treat major depressive disorder (MDD), or clinical depression, as well as postpartum depression, which affect millions of people.
Ads
related to: fda approved for postpartum depressionbabylist.com has been visited by 10K+ users in the past month